REGN
38
-2
EXR
57
2
AXP
67
-2
LH
40
-5
WDC
37
-3
PCAR
56
-5
CI
45
-3
STZ
52
-6
BMY
55
-8
MRO
50
4
HCP
56
-8
TSN
50
-2
SYY
49
9
LUV
45
-2
HSIC
45
5
SWK
50
-5
ECL
55
-2
IR
63
-3
ETN
75
-3
SNA
70
-5
REGN
38
-2
EXR
57
2
AXP
67
-2
LH
40
-5
WDC
37
-3
PCAR
56
-5
CI
45
-3
STZ
52
-6
BMY
55
-8
MRO
50
4
HCP
56
-8
TSN
50
-2
SYY
49
9
LUV
45
-2
HSIC
45
5
SWK
50
-5
ECL
55
-2
IR
63
-3
ETN
75
-3
SNA
70
-5
Financhill
Back

KraneShares MSCI All China Hlth Care ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
33

KURE
KraneShares MSCI All China Hlth Care ETF

Last Price:
15.43
Seasonality Move:
-0.04%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
33
KraneShares MSCI All China Hlth Care ETF (KURE) is a Sell

Is KraneShares MSCI All China Hlth Care ETF a Buy, Sell or Hold?

  • The current KraneShares MSCI All China Hlth Care ETF [KURE] share price is $14.91. The Score for KURE is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • KURE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KURE Stock Price Chart

What is KraneShares MSCI All China Hlth Care ETF's stock price today?

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

KURE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 42.93 Sell
Chaikin Money Flow: -909 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.22 - 15.92) Sell
Bollinger Bands (100): (13.03 - 15.95) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

KURE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.47 Sell
20-day SMA: 15.55 Sell
50-day SMA: 15.46 Sell
200-day SMA: 14.6 Buy
8-day EMA: 15.34 Sell
20-day EMA: 15.54 Sell
50-day EMA: 15.36 Sell
200-day EMA: 15.19 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

KraneShares MSCI All China Hlth Care ETF Earnings Growth & KURE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

KraneShares MSCI All China Hlth Care ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):